Skip to main content
Denis Chem Lab Limited logo

Denis Chem Lab Limited — Investor Relations & Filings

Ticker · 537536 ISIN · INE051G01012 LEI · 9845001H3A68F5E97D79 BSE.NS Manufacturing
Open in API
Filings indexed 2 across all filing types
Latest filing 2026-05-23 Regulatory Filings
Country IN India
Listing BSE.NS 537536

About Denis Chem Lab Limited

http://www.denischemlab.com

Denis Chem Lab Limited specializes in the production of sterile injectables and intravenous (IV) fluids. The company manufactures a comprehensive range of Large Volume Parenterals (LVP) and Small Volume Parenterals (SVP), including electrolyte replenishments, osmotic diuretics, and specialized infusion therapies. Utilizing advanced manufacturing technologies such as Blow-Fill-Seal (BFS) and Three-Piece technology, the firm ensures high standards of sterility and product integrity. Its portfolio serves diverse therapeutic areas, catering to hospitals and healthcare providers. The company maintains rigorous quality control systems and adheres to international regulatory standards to support its extensive distribution network across various markets.

Recent filings

Filing Released Lang Actions
We are attaching herewith Annual Secretarial Compliance Report for the year 2025-26 issued by M/s. kashyap R Mehta and Partners, Company Secretaries.
Regulatory Filings Classification · 85% confidence The document is an Annual Secretarial Compliance Report prepared by Practising Company Secretaries under SEBI LODR Regulation 24A for FY2025-26. It is an attestation/certification of statutory compliance rather than a substantive financial report or AGM materials, call transcript, or management discussion. Under the Certification Rule, such compliance certificates are classified as a general Regulatory Filing (RNS).
2026-05-23 English
Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve and take on record the Audited ....
Regulatory Filings Classification · 71% confidence The document is a notice addressed to the stock exchange under SEBI LODR, informing of a Board Meeting date to consider and approve the audited financial results and dividend recommendation. It does not contain any actual financial statements or data, nor does it announce the results or dividend amounts. It is a regulatory intimation to the exchange rather than the report itself (not a 10-K/Annual Report or Interim Report), nor is it a management change, call transcript, or other specialized report. Therefore it falls into the catch‐all “Regulatory Filings” category.
2026-05-21 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.